Upon light activation, the VDC binds to heparan sulfate proteoglycans (HSPGs) on tumor cells, subsequently leading to tumor cell necrosis through oxidative stress or immune-mediated tumor cell killing through the damage-associated molecular patterns (DAMPs) pathway. Here, CD44 is linked to neoplasm.